BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 15002365)

  • 1. Enlarged prostate. Therapies have advanced.
    Mayo Clin Health Lett; 2004 Jan; 22(1):4-5. PubMed ID: 15002365
    [No Abstract]   [Full Text] [Related]  

  • 2. Update on minimally invasive therapies for benign prostatic hyperplasia.
    Turini GA; Pareek G
    Med Health R I; 2009 Oct; 92(10):336-8. PubMed ID: 19911713
    [No Abstract]   [Full Text] [Related]  

  • 3. [Advances in minimally invasive treatment of benign prostatic hyperplasia].
    Yu B; Wang Z
    Zhonghua Nan Ke Xue; 2007 Aug; 13(8):739-43. PubMed ID: 17918717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of standard transurethral resection, transurethral vapour resection and holmium laser enucleation of the prostate for managing benign prostatic hyperplasia of >40 g.
    Kamat NN
    BJU Int; 2006 Oct; 98(4):918. PubMed ID: 16978299
    [No Abstract]   [Full Text] [Related]  

  • 5. [Minimally invasive treatment of benign prostatic hyperplasia].
    Nørby B
    Ugeskr Laeger; 2004 Feb; 166(8):688-90. PubMed ID: 15042812
    [No Abstract]   [Full Text] [Related]  

  • 6. A clinical outcomes and cost analysis comparing photoselective vaporization of the prostate to alternative minimally invasive therapies and transurethral prostate resection for the treatment of benign prostatic hyperplasia.
    Stovsky MD; Griffiths RI; Duff SB
    J Urol; 2006 Oct; 176(4 Pt 1):1500-6. PubMed ID: 16952668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Holmium laser-enucleation of the prostate enables early catheter removal.
    Madersbacher S; Marszalek M; Ponholzer A; Brössner C
    BJU Int; 2004 Oct; 94(6):931-3. PubMed ID: 15476539
    [No Abstract]   [Full Text] [Related]  

  • 8. Is classical transurethral resection of the prostate, the gold standard endoscopic treatment for benign prostate hyperplasia, in real danger of being replaced?
    Geavlete P
    Eur Urol; 2010 Sep; 58(3):356-8; discussion 358-9. PubMed ID: 20825757
    [No Abstract]   [Full Text] [Related]  

  • 9. Practice patterns in benign prostatic hyperplasia surgical therapy: the dramatic increase in minimally invasive technologies.
    Yu X; Elliott SP; Wilt TJ; McBean AM
    J Urol; 2008 Jul; 180(1):241-5; discussion 245. PubMed ID: 18499180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Commentary on holmium laser enucleation versus TURP.
    Kaplan SA
    J Urol; 2008 May; 179(5 Suppl):S91. PubMed ID: 18405766
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of standard transurethral resection, transurethral vapour resection and holmium laser enucleation of the prostate for managing benign prostatic hyperplasia of >40 g.
    Gupta N; Sivaramakrishna ; Kumar R; Dogra PN; Seth A
    BJU Int; 2006 Jan; 97(1):85-9. PubMed ID: 16336334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Durability and cost-effectiveness of transurethral needle ablation of the prostate as an alternative to transurethral resection of the prostate when alpha-adrenergic antagonist therapy fails.
    Rosario DJ; Phillips JT; Chapple CR
    J Urol; 2007 Mar; 177(3):1047-51; discussion 1051. PubMed ID: 17296409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comment to the study: experiences in the treatment of benign prostatic hyperplasia with high power potassium-titanyl-phosphate (KTP)].
    Jeromin LM
    Wiad Lek; 2006; 59(3-4):292. PubMed ID: 16813284
    [No Abstract]   [Full Text] [Related]  

  • 14. Photoselective potassium-titanyl-phosphate (KTP) laser vaporization of the prostate (PVP) vs transurethral resection of the prostate (TURP).
    Malek RS
    Urology; 2008 Sep; 72(3):718-9. PubMed ID: 18597826
    [No Abstract]   [Full Text] [Related]  

  • 15. [TUVRP and HOLEP as effective as TURP].
    Witte F
    Aktuelle Urol; 2007 Jan; 38(1):8-9. PubMed ID: 17354351
    [No Abstract]   [Full Text] [Related]  

  • 16. Photoselective vaporization (PVP) versus transurethral resection of the prostate (TURP): a prospective bi-centre study of perioperative morbidity and early functional outcome.
    Bachmann A; Schürch L; Ruszat R; Wyler SF; Seifert HH; Müller A; Lehmann K; Sulser T
    Eur Urol; 2005 Dec; 48(6):965-71; discussion 972. PubMed ID: 16126327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Transurethral holmium laser enucleation of the prostate for the treatment of benign prostatic hyperplasia].
    Wu Z; Ding Q; Jiang HW; Chen ZX; Zhang HW; Li CJ; Zhang YF
    Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(36):2560-2. PubMed ID: 17198566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Editorial comment on: a review of the recent evidence (2006-2008) for 532-nm photoselective laser vaporisation and holmium laser enucleation of the prostate.
    Rassweiler J
    Eur Urol; 2009 Jun; 55(6):1357. PubMed ID: 19361917
    [No Abstract]   [Full Text] [Related]  

  • 19. Re: Burke et al.: systematic review and meta-analysis of transurethral resection of the prostate versus minimally invasive procedures for the treatment of benign prostatic obstruction (Urology 2010;75: 1015-1022).
    Mamoulakis C; de la Rosette JJ; Ubbink DT
    Urology; 2010 May; 75(5):1235-6; author reply 1236-7. PubMed ID: 20451750
    [No Abstract]   [Full Text] [Related]  

  • 20. A review of the recent evidence (2006-2008) for 532-nm photoselective laser vaporisation and holmium laser enucleation of the prostate.
    Naspro R; Bachmann A; Gilling P; Kuntz R; Madersbacher S; Montorsi F; Reich O; Stief C; Vavassori I
    Eur Urol; 2009 Jun; 55(6):1345-57. PubMed ID: 19361906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.